Accelevation Prices $540M IPO at $18/Share; Olympus Retains 85% Voting Control
ACCV is trading near its 52-week low of $17.51 (0.2% above the low).
Summary
Accelevation Holdings Corp. priced its IPO at $18.00 per share, raising $540 million gross. The company nets $170.6 million to pay down debt, while Olympus Partners retains 85% voting control and a Tax Receivable Agreement creates a large future cash obligation. The IPO closed on October 1, 2026, with underwriters holding a 30-day option for 4.5 million additional shares.
Updated with an SEC 8-K filing · What changed
Updates
· SEC 8-K — IPO closed on October 1, 2026; underwriters have 30-day option for 4.5M additional shares.
Key Events · Financing and Capital Events · ACCV
-
New · · SEC 8-K
Underwriters' Overallotment Option
Underwriters have a 30-day option to purchase up to 4.5 million additional shares.
-
Updated · · SEC 8-K
IPO Priced at $18.00 Per Share and Closed
30,000,000 Class A shares priced at $18.00 each for $540 million gross proceeds. Company offering 10M primary shares; selling stockholders offering 20M secondary shares. The IPO closed on October 1, 2026.
-
Net Proceeds to Repay Debt
Company nets approximately $170.6 million after underwriting discounts ($0.945/share), to be used to repay outstanding borrowings under its Credit Agreement, which had $651.5 million outstanding at 8.772% weighted average interest.
-
Olympus Retains 85% Voting Control
Principal stockholder Olympus Partners will control approximately 85% of combined voting power post-offering (83% if overallotment exercised), qualifying Accelevation as a 'controlled company' under Nasdaq rules.
-
Tax Receivable Agreement Creates Future Obligation
Up-C structure includes a Tax Receivable Agreement requiring payment of 85% of certain tax savings to TRA Rights Holders. If all LLC Units exchanged, estimated payments total $589.8 million over 15 years.
Analysis · ACCV · Manufacturing
Accelevation Holdings Corp. has finalized terms for its initial public offering, pricing 30 million Class A shares at $18.00 each for $540 million in gross proceeds. The company will receive approximately $170.6 million from its 10 million primary shares, which it intends to use to repay a portion of its $651.5 million term loan debt. The remaining 20 million shares are being sold by existing stockholders, including Olympus Partners, which will retain approximately 85% of combined voting power through its Class A and Class B holdings. The Up-C structure and Tax Receivable Agreement create a substantial future cash obligation—potentially $589.8 million over 15 years if all LLC Units are exchanged—that will reduce cash available to public shareholders. Investors buying at $18.00 face immediate dilution of $19.67 per share, as pro forma net tangible book value is negative $1.67 per share. The offering closed on October 1, 2026, and the underwriters have a 30-day option to purchase up to 4.5 million additional shares.
How filings like this one have moved
In the 30 days to Oct 4, 2026, 36.7% of the 1008 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.64%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, ACCV was trading at $17.55 on NASDAQ in the Manufacturing sector. The 52-week trading range was $17.51 to $18.10. This filing was assessed with neutral market sentiment and an importance score of 8 out of 10.